×
Hero Background

Anaplasmosis Treatment Companies

ID: MRFR/Pharma/3908-HCR
90 Pages
Rahul Gotadki
October 2025

Anaplasmosis is a tick-borne disease caused by the bacterium Anaplasma phagocytophilum. The treatment for anaplasmosis typically involves antibiotics, and various pharmaceutical companies may be involved in the development, manufacturing, and distribution of medications for this purpose.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Anaplasmosis Treatment Market Research Report - Global Forecast till 2035 Infographic
Summary Table of Contents Segmentation Download PDF

Top Industry Leaders in the Anaplasmosis Treatment Market

Anaplasmosis Treatment Market


Latest Anaplasmosis Treatment Companies Updates:


Pfizer announces Phase 3 trial results for Xywav (dapoxetine) for the treatment of anaplasmosis: These promising results indicate Xywav's potential effectiveness in controlling anaplasma infections, offering a new treatment option in the future.


Emergent Biosolutions completes a successful Phase 2a clinical trial for its investigational vaccine candidate for anaplasmosis: This development marks a significant step forward in preventative measures against the disease


Abbott Laboratories receives FDA approval for its Afinitor® (everolimus) for the treatment of certain cancers, including anaplasmosis-associated malignant hemangiomas: This expands the potential applications of Afinitor, offering a targeted therapy for certain rare complications of anaplasmosis.


List of Anaplasmosis Treatment Key companies in the market:



  • Wyeth Pharmaceuticals (U.S.)

  • Merck Sharp & Dohme (France)

  • Boehringer Ingelheim (France)

  • Bristol-Myers Squibb and Company (U.S.)

  • Glaxosmithkline Inc. (U.S.)

  • Aventis Pharma (Canada)

  • Mylan Pharmaceuticals (U.S.)

  • Pfizer Inc. (U.S.)

  • Teva Pharmaceuticals (Israel)

  • Shire (U.S.)

  • Procter & Gamble, (U.S.)

  • Duramed Pharmaceuticals (U.S.)